Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 985

1.

Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice?

Bruchbacher A, Soria F, Hassler M, Shariat SF, D'Andrea D.

Curr Opin Urol. 2018 Sep 3. doi: 10.1097/MOU.0000000000000546. [Epub ahead of print]

PMID:
30188332
2.

[Palliative surgery for metastatic urothelial cancer].

Hübner N, Shariat SF.

Aktuelle Urol. 2018 Sep;49(5):412-416. doi: 10.1055/a-0659-9827. Epub 2018 Sep 5. German.

PMID:
30184599
4.

Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.

Mazzone E, Nazzani S, Preisser F, Tian Z, Marchioni M, Bandini M, Capitanio U, Kapoor A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, I Karakiewicz P.

Cancer Epidemiol. 2018 Aug 30;56:118-125. doi: 10.1016/j.canep.2018.08.006. [Epub ahead of print]

PMID:
30173050
5.

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

Soria F, Pisano F, Gontero P, Palou J, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes JA, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Sylvester R.

World J Urol. 2018 Aug 31. doi: 10.1007/s00345-018-2450-0. [Epub ahead of print]

PMID:
30171454
6.

Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice?

Soria F, D'Andrea D, Pohar K, Shariat SF, Lotan Y.

Curr Opin Urol. 2018 Aug 27. doi: 10.1097/MOU.0000000000000545. [Epub ahead of print]

PMID:
30157039
7.

Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Saad F, Chun FK, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Int J Urol. 2018 Aug 26. doi: 10.1111/iju.13780. [Epub ahead of print]

PMID:
30146729
8.

PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact.

Grubmüller B, Baltzer PA, Hartenbach S, D'Andrea D, Helbich TH, Haug A, Goldner G, Wadsak W, Pfaff S, Mitterhauser M, Balber T, Berroterán-Infante N, Grahovac M, Babich JW, Seitz C, Kramer G, Susani M, Mazal P, Kenner L, Shariat SF, Hacker M, Hartenbach M.

Clin Cancer Res. 2018 Aug 23. pii: clincanres.0768.2018. doi: 10.1158/1078-0432.CCR-18-0768. [Epub ahead of print]

PMID:
30139879
9.

What to do during Bacillus Calmette-Guérin shortage? Valid strategies based on evidence.

Abufaraj M, Mostafid H, Shariat SF, Babjuk M.

Curr Opin Urol. 2018 Aug 21. doi: 10.1097/MOU.0000000000000544. [Epub ahead of print]

PMID:
30138122
10.

Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer Patients.

Vartolomei L, Ferro M, Mirone V, Shariat SF, Vartolomei MD.

Bladder Cancer. 2018 Jul 30;4(3):319-326. doi: 10.3233/BLC-180181.

11.

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.

Stangl-Kremser, Mari A, D'Andrea D, Kimura S, Resch I, Shariat SF, Klatte T.

Urol Int. 2018;101(2):197-200. doi: 10.1159/000489013. Epub 2018 Aug 8.

PMID:
30089304
12.

Prognostic value of concomitant carcinoma in situ in the radical cystectomy specimen: A systematic review and meta-analysis.

Kimura S, Mari A, Foerster B, Abufaraj M, Vartolomei MD, Stangl-Kremser J, Karakiewicz PI, Egawa S, Shariat SF.

J Urol. 2018 Aug 2. pii: S0022-5347(18)43637-3. doi: 10.1016/j.juro.2018.05.162. [Epub ahead of print] Review.

PMID:
30077559
13.

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.

Vartolomei MD, Ferro M, Cantiello F, Lucarelli G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, De Berardinis E, Damiano R, Perdona S, Verze P, La Rocca R, Borghesi M, Schiavina R, Brunocilla E, Almeida GL, Bove P, Lima E, Grimaldi G, Autorino R, Crisan N, Abu Farhan AR, Battaglia M, Serretta V, Russo GI, Morgia G, Terracciano D, Musi G, de Cobelli O, Mirone V, Shariat SF.

Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30183-6. doi: 10.1016/j.clgc.2018.07.003. [Epub ahead of print]

PMID:
30077463
14.

Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

D'Andrea D, Shariat SF, Soria F.

Eur Urol. 2018 Jul 30. pii: S0302-2838(18)30544-X. doi: 10.1016/j.eururo.2018.07.022. [Epub ahead of print] No abstract available.

PMID:
30072209
15.

Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?

Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V; European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer.

Eur Urol Focus. 2018 Jul 27. pii: S2405-4569(18)30189-5. doi: 10.1016/j.euf.2018.07.023. [Epub ahead of print]

PMID:
30061076
16.

Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.

Kimura S, Soria F, D'Andrea D, Foerster B, Abufaraj M, Vartolomei MD, Karakiewicz PI, Mathieu R, Moschini M, Rink M, Egawa S, Shariat SF, Gust KM.

Clin Genitourin Cancer. 2018 Jul 6. pii: S1558-7673(18)30415-4. doi: 10.1016/j.clgc.2018.07.002. [Epub ahead of print]

PMID:
30061034
17.

Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.

Suarez-Ibarrola R, Abufaraj M, Shariat SF.

Curr Opin Urol. 2018 Sep;28(5):485-490. doi: 10.1097/MOU.0000000000000527.

PMID:
30044319
18.

Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.

Preisser F, Mazzone E, Nazzani S, Bandini M, Tian Z, Marchioni M, Steuber T, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol. 2018 Jul 20. pii: S0302-2838(18)30484-6. doi: 10.1016/j.eururo.2018.07.006. [Epub ahead of print]

PMID:
30037529
19.

Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.

Vartolomei MD, Kimura S, Vartolomei L, Shariat SF.

Eur Urol Focus. 2018 Jul 14. pii: S2405-4569(18)30172-X. doi: 10.1016/j.euf.2018.07.006. [Epub ahead of print] Review.

PMID:
30017901
20.

Cost analysis of prostate cancer detection including the prostate health index (phi).

Mathieu R, Castelli C, Fardoun T, Peyronnet B, Shariat SF, Bensalah K, Vincendeau S.

World J Urol. 2018 Jul 6. doi: 10.1007/s00345-018-2362-z. [Epub ahead of print]

PMID:
29980838

Supplemental Content

Loading ...
Support Center